Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 ... They’ve continued to deny claims of any wrongdoing.Collectively, family members have been estimated ...

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...